Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 116

Sort by

Sort Order Select

Journal Articles

Pulmonary Hypertension and Hemoglobin F Values in Patients with Sickle Cell Disease

Emma Hazenberg, Daniel Herrera, Heath Aston, Elexis Price, Girindra Raval, Siera Gollan, Hongyan Xu, Abdullah Kutlar, Casey Gazza, Satya Jella, Neha Balachandran, Asim Ahmed, Elena Wernecke, Ahmed Shetewi

Blood (2024) 144 (Supplement 1): 5346.

https://doi.org/10.1182/blood-2024-208936

Published: 2024

Journal Articles

Retention of Young Adults with Sickle Cell Disease in Outpatient Adult Care

Isabela Pavkov, Abdullah Kutlar, Siera Gollan

Blood (2024) 144 (Supplement 1): 5355.

https://doi.org/10.1182/blood-2024-211549

Published: 2024

Journal Articles

Mean Corpuscular Hemoglobin Is an Important Modulator of HbF/F-Cell and Response to Gene Therapy and Hydroxyurea in Sickle Cell Disease

Martin H. Steinberg, Carlo Brugnara, Abdullah Kutlar, Paola Sebastiani

Blood (2024) 144 (Supplement 1): 5274.

https://doi.org/10.1182/blood-2024-205808

Published: 2024

Journal Articles

Maternal Outcomes in Pregnant Women Admitted with Sickle Cell Disease: A Retrospective Study Involving the National Inpatient Sample (NIS 2016-2021) Database

Sindhu Chandra Pokhriyal, Sindu Iska, Mark Anthony Ntow, Ruchi Yadav, Barath Prashanth Sivasubramanian, Kalpana Panigrahi, Abdullah Kutlar

Blood (2024) 144 (Supplement 1): 391.

https://doi.org/10.1182/blood-2024-208784

Published: 2024

Journal Articles

Hindsight 20/20: The Role of Hemoglobin F in Sickle Cell Retinopathy

Elexis Price, Heath Aston, Emma Hazenberg, Girindra Raval, Siera Gollan, Elena Wernecke, Faizan Boghani, Casey Gazza, Asim Ahmed, Neha Balachandran, Daniel Herrera, Satya Jella, Ahmed Shetewi, Hongyan Xu, Abdullah Kutlar

Blood (2024) 144 (Supplement 1): 3884.

https://doi.org/10.1182/blood-2024-208897

Published: 2024

Journal Articles

Hemoglobin F and Incidence of Thrombotic Event in Sickle Cell Disease

Heath Aston, Casey Gazza, Faizan Boghani, Asim Ahmed, Neha Balachandran, Emma Hazenberg, Daniel Herrera, Satya Jella, Ahmed Shetewi, Elena Wernecke, Siera Gollan, Hongyan Xu, Abdullah Kutlar, Girindra Raval

Blood (2023) 142 (Supplement 1): 5316.

https://doi.org/10.1182/blood-2023-179636

Published: 2023

Journal Articles

Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial

Blood (2023) 142 (Supplement 1): 571.

https://doi.org/10.1182/blood-2023-180780

Published: 2023

Journal Articles

Sex-Related Differences in Fetal Hemoglobin Levels in Sickle Cell Patients

Neha Balachandran, Satya Jella, Heath Aston, Faizan Boghani, Casey Gazza, Emma Hazenberg, Daniel Herrera, Elena Wernecke, Ahmed Shetewi, Siera Gollan, Asim Ahmed, Hongyan Xu, Girindra Raval, Abdullah Kutlar

Blood (2023) 142 (Supplement 1): 5304.

https://doi.org/10.1182/blood-2023-190193

Published: 2023

Journal Articles

Preclinical and Clinical Use of AB1, a DNMT1 Protein Depleter, to Upregulate Fetal Hemoglobin in Townes Sickle Cell Disease (SCD) Mice and Patients with SCD

Nirmish Shah, Girindra Raval, Abdullah Kutlar, Niren Patel, Mayuko Takezaki, Biaoru Li, Manickam Alagar, Hongyan Xu, Kelly Blackburn, Santhosh Vadivelu, Robert Schaub, David Santos, Betty Pace

Blood (2023) 142 (Supplement 1): 276.

https://doi.org/10.1182/blood-2023-188165

Published: 2023

Journal Articles

Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling Parameters

Kevin H.M. Kuo, Sylvia Titi Singer, Gershwin Theophilus Blyden, Lanetta Bronté-Hall, Aidan Faller, Abdullah Kutlar, Frans A. Kuypers, Aliya U. Zaidi, Patrick C. Hines, Niren Patel, Sandra Larkin, Hanny Al-Samkari, Sujit Sheth, Seyed Mehdi Nouraie, Susan Perrine

Blood (2023) 142 (Supplement 1): 1148.

https://doi.org/10.1182/blood-2023-184627

Published: 2023

Journal Articles

Correlation between Disease Biomarkers and Hemoglobin F Levels in Sickle Cell Patients

Casey Gazza, Elena Wernecke, Emma Hazenberg, Heath Aston, Faizan Boghani, Girindra Raval, Siera Gollan, Asim Ahmed, Neha Balachandran, Daniel Herrera, Satya Jella, Ahmed Shetewi, Hongyan Xu, Abdullah Kutlar

Blood (2023) 142 (Supplement 1): 5312.

https://doi.org/10.1182/blood-2023-190387

Published: 2023

Journal Articles

Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease: Final Interim Analysis Results from the Phase 2 Solace-Adults Study

Julie Kanter, Sarah Mennito, Santosh M Nair, Deepa Manwani, Abdullah Kutlar, Nirmish Shah, Deborah Keefe, Hariprasad Madhamshetty, Evgeniya Reshetnyak, Anisha E Mendonza, Darla K. Liles

Blood (2023) 142 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2023-173342

Published: 2023

Journal Articles

Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

Abdullah Kutlar, Vikas Joshi, Andreas Brueckner, Julie Kanter, Darla K. Liles, Jeremie Lincy, Rahul Manjare, Yvonne Dei Adomakoh, Matthew M. Heeney, Mariane de Montalembert, Deborah Keefe, Kwaku Marfo, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 1139.

https://doi.org/10.1182/blood-2023-188639

Published: 2023

Journal Articles

A-two to the rescue

Abdullah Kutlar

Blood (2022) 140 (21): 2187–2188.

https://doi.org/10.1182/blood.2022017783

Published: 2022

Journal Articles

Early Effects of a Repurposed Therapeutic PB-04 in Beta Thalassemia Intermedia and in Transgenic Sickle Mice

Betty S. Pace, Seyed Mehdi Nouraie, Kevin H.M. Kuo, Sylvia Singer, Mayuko Takezaki, Biaoru Li, Aidan D Faller, Abdullah Kutlar, Susan P Perrine

Blood (2022) 140 (Supplement 1): 5360–5361.

https://doi.org/10.1182/blood-2022-169310

Published: 2022

Journal Articles

Proteomics of Plasma from Patients with Sickle Cell Disease with and without Chronic Pain: A Pilot Biomarker Discovery Study

Mycal Casey, Brandon Gramazio, Florence Urum, Niren Patel, Wenbo Zhi, Abdullah Kutlar

Blood (2022) 140 (Supplement 1): 5414–5415.

https://doi.org/10.1182/blood-2022-168950

Published: 2022

Journal Articles

Mortality in Adults with Sickle Cell Disease: Results from the Sickle Cell Disease Implementation Consortium (SCDIC) Registry

Franklin Njoku, Norma Pugh, Marsha Treadwell, Jeffrey A. Glassberg, Abdullah Kutlar, Robert Gibson, Nirmish Shah, Victor R. Gordeuk, Lewis L. Hsu, Jane Hankins, Allison A. King, Julie Kanter

Blood (2022) 140 (Supplement 1): 2586–2588.

https://doi.org/10.1182/blood-2022-168856

Published: 2022

Journal Articles

Factors Associated with Thrombosis in Hospitalized COVID Patients

Girindra Ghanshyam Raval, Abdullah Kutlar

Blood (2022) 140 (Supplement 1): 11348–11349.

https://doi.org/10.1182/blood-2022-162644

Published: 2022

Journal Articles

The Benefits Trial of PB-04 to Evaluate Safety, PK, and Preliminary Efficacy in Inducing Fetal Globin Expression in Beta Thalassemia Intermedia and Sickle Cell Disease

Kevin H.M. Kuo, Sylvia Singer, Sujit Sheth, Hanny Al-Samkari, Gershwin Blyden, Lanetta Bronte-Hall, Betty S. Pace, Abdullah Kutlar, Franciscus A. Kuypers, Aidan D Faller, Seyed Mehdi Nouraie, Pramod Terse, Haksong Jin, Xin Xu, Asaf Alimardanov, Arthur J. Sytkowski, Sharie Haugabook, Susan P Perrine

Blood (2021) 138 (Supplement 1): 4159.

https://doi.org/10.1182/blood-2021-148909

Published: 2021

Journal Articles

Transfusional Iron Overload in Sickle Cell Patients:Outcomes of Chelation Therapy

Daniel Adamkiewicz, Abhishek A. Mangaonkar, James Son, Hongyan Xu, Leigh Wells, Latanya Bowman, Abdullah Kutlar

Blood (2021) 138 (Supplement 1): 4177.

https://doi.org/10.1182/blood-2021-151743

Published: 2021

NARROW

Pulmonary Hypertension and Hemoglobin F Values in Patients with Sickle Cell Disease

Retention of Young Adults with Sickle Cell Disease in Outpatient Adult Care

Mean Corpuscular Hemoglobin Is an Important Modulator of HbF/F-Cell and Response to Gene Therapy and Hydroxyurea in Sickle Cell Disease

Maternal Outcomes in Pregnant Women Admitted with Sickle Cell Disease: A Retrospective Study Involving the National Inpatient Sample (NIS 2016-2021) Database

Hindsight 20/20: The Role of Hemoglobin F in Sickle Cell Retinopathy

Hemoglobin F and Incidence of Thrombotic Event in Sickle Cell Disease

Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial

Sex-Related Differences in Fetal Hemoglobin Levels in Sickle Cell Patients

Preclinical and Clinical Use of AB1, a DNMT1 Protein Depleter, to Upregulate Fetal Hemoglobin in Townes Sickle Cell Disease (SCD) Mice and Patients with SCD

Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling Parameters

Correlation between Disease Biomarkers and Hemoglobin F Levels in Sickle Cell Patients

Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease: Final Interim Analysis Results from the Phase 2 Solace-Adults Study

Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

A-two to the rescue

Early Effects of a Repurposed Therapeutic PB-04 in Beta Thalassemia Intermedia and in Transgenic Sickle Mice

Proteomics of Plasma from Patients with Sickle Cell Disease with and without Chronic Pain: A Pilot Biomarker Discovery Study

Mortality in Adults with Sickle Cell Disease: Results from the Sickle Cell Disease Implementation Consortium (SCDIC) Registry

Factors Associated with Thrombosis in Hospitalized COVID Patients

The Benefits Trial of PB-04 to Evaluate Safety, PK, and Preliminary Efficacy in Inducing Fetal Globin Expression in Beta Thalassemia Intermedia and Sickle Cell Disease

Transfusional Iron Overload in Sickle Cell Patients:Outcomes of Chelation Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only